1. Clinical trials report

   • Alan B. Weder

   Report 26 April 2007 Pages: 3 - 4

2. Are Studies on BMI and Heart Disease a “Waist”?

   • Arya M. Sharma

   Clinical trials report 26 April 2007 Pages: 5 - 6

3. Repressive/defensive coping, blood pressure, and cardiovascular rehabilitation

   • Lillian Gleiberman

   OriginalPaper 26 April 2007 Pages: 7 - 12

4. Evolution of blood pressure regulation in humans

   • J. Hunter Young

   OriginalPaper 26 April 2007 Pages: 13 - 18

5. Gene therapy for stroke: 2006 overview

   • Yi Chu
   • Jordan D. Miller
   • Donald D. Heistad

   OriginalPaper 26 April 2007 Pages: 19 - 24

6. Genetics of salt-sensitive hypertension

   • Pasquale Strazzullo
   • Ferruccio Galletti

   OriginalPaper 26 April 2007 Pages: 25 - 32

7. Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome?

   • Jaswinder K. Sethi

   OriginalPaper 26 April 2007 Pages: 33 - 38

8. Painful lessons: COX-2 inhibitors, NSAIDs, and hypertension

   • Frank Ruschitzka

   Report 26 April 2007 Pages: 41 - 44

9. Mineralocorticoid receptor antagonists

   • Hari Krishnan Parthasarathy
   • Thomas M. MacDonald

   OriginalPaper 26 April 2007 Pages: 45 - 52

10. Therapeutic potential of blockade of the Urotensin II system in systemic hypertension

    • Henry Krum
    • Will Kemp

    OriginalPaper 26 April 2007 Pages: 53 - 58

11. Endothelin-receptor antagonists in arterial hypertension: Further indications?

    • Isabella Sudano
    • Matthias Hermann
    • Frank T. Ruschitzka

    OriginalPaper 26 April 2007 Pages: 59 - 65

12. Cigarette smoking as a risk factor for atherosclerosis and renal disease: Novel pathogenic insights

    • Carlos Mercado
    • Edgar A. Jaimes

    OriginalPaper 26 April 2007 Pages: 66 - 72

13. COX-2 and the vasculature: Angel or evil?

    • Chiara Cuccurullo
    • Andrea Mezzetti
    • Francesco Cipollone

    OriginalPaper 26 April 2007 Pages: 73 - 80